*Pakistan is likely to become first country to complete immunoglobulin (IG)therapy research needed to treat coronavirus, says Scientists at Karachi’sDow University of Health Sciences (DUHS).*

As per details, scientists – who are conducting clinical trials ofimmunoglobulin (C-IVIG) therapy for the treatment novel coronavirus(COVID-19) – say, as quoted by Arab News, ‘severe’ patients who hadreceived the product had a 100 percent recovery rate.

The therapy uses immunoglobulin (IG), which is rich in the antibodies thattarget the virus.

The scientists say continues infusion of immunoglobulin can neutralise theinfection in patients and shorten the course of the disease.

In June, DUHS started trail of the therapy on 30 participants, most fromthe high-risk group of people above the age of 60, with many suffering fromdiabetes, hypertension and other comorbidities.

Dr. Shaukat Ali, head of biotechnology at DUHS said, “The trials are veryencouraging and remarkable.”

“At the moment, what we have seen is that all severe patients who receivedC-IVIG treatment had 100 percent recovery ratio while in critical patientsthe recovery ratio was 50 to 60 percent.”

Besides the high recovery rate, the team observed that therapysignificantly reduced the period of hospitalisation, said Ali.

“The results show that the number of hospitalisation days were reduced tosix and a half days for severe patients, which is very encouraging becausenormally a severe patient would occupy hospital resources for 20 to 25days.”

Ali said Pakistan was the first country to develop the immunoglobulinsolution in April 2020.